Abstract: N-(3-Dialkylamino-2-propenylidene)-N-alkylalkanaminium salts substituted in the 2-position with an ether or thioether and having the formula ##STR1## are active as hypoglycemic agents.

Abstract: N-(3-Dialkylamino-2-propenylidene)-N-alkylalkanaminium salts substituted in the 2-position with an ether or thioether and having the formula ##STR1## are active as hypoglycemic agents.

Abstract: 4-[(4-Isoquinolinylmethyl)amino]benzoic acid derivatives useful as selective thromboxane synthetase inhibitors are described herein. The compounds are obtained from the appropriate 4-isoquinolinecarboxylic acid derivative and an aminobenzoic acid derivative. This gives the corresponding Schiff base which is then reduced to give the desired compounds.

Abstract: N-(3-Dialkylamino-2-propenylidene)-N-alkylalkanaminium salts substituted in the 2-position with an ether or thioether and having the formula ##STR1## are active as hypoglycemic agents.

Abstract: Tetrazolobenzotriazine compounds such as 7-chlorotetrazolo[4,5-C][1,2,3]benzotriazine are prepared by the reaction of the corresponding substituted 5-(2-aminophenyl)tetrazole with nitrous acid. These new compounds are useful as initiating explosives, propellants, and chemical blowing agents.

Abstract: Hypoglycemic phenylpropynylamino benzoic acids and the pharmaceutically-acceptable salts thereof, a method for lowering serum sugars and hypoglycemic compositions useful for the treatment of diabetes.

Abstract: A novel container sorting and handling system is provided for sorting a plurality of diverse types of containers into preselected types for either reuse, reclamation or disposal depending upon the type of container. The sorting system comprises a housing having a sorting station defined therein and an infeed conveyor for sequentially and individually transporting containers to the sorting station. At the sorting station the individual containers are rotated by a roller in order to bring the UPC Code, bar code or other code on each container into alignment with an optical scanner at the sorting station. The optical scanner produces an output signal representative of the bar code and this is in turn fed to a computer which compares the signal from the optical scanner with a plurality of prestored values in the computer. As a result of this comparison, the computer generates an output signal representative of the type of container at the sorting station.

Abstract: Substituted or unsubstituted benzylaminobenzene alkanoic or alkenoic acids are disclosed as hypolipidemic agents and especially as hypocholesterolemic agents; along with a method of use and pharmaceutical compositions thereof.

Abstract: A method for treating hyperglycemia in a mammal which comprises administering internally to said mammal a hypoglycemic amount of an arylamino benzoic acid or pharmaceutically-acceptable salt thereof, wherein aryl represents phenyl, substituted phenyl, thienyl or substituted thienyl.

Abstract: A method for treating hyperglycemia in a mammal which comprises administering to said mammal a hyperglycemic amount of a derivative of 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid or a pharmaceutically-acceptable salt thereof.

Abstract: Halo-substituted 4-(((thienyl)methyl)amino)benzoic acids, the corresponding esters and salts thereof, and a method for lowering serum lipid levels in mammals.

Abstract: The compound 4-((3-methoxyphenylmethyl)amino)benzoic acid and the pharmaceutically-acceptable salts thereof used to treat hyperlipidemia, especially hypercholesterolemia, and pharmaceutical compositions thereof.

Abstract: A method for treating hyperlipidemia in primates using the compound 4-((4-fluorophenylmethyl)amino)benzoic acid, a pharmaceutically-acceptable salt or an ester thereof.

Abstract: A method for treating hyperglycemia in a mammal which comprises administering internally to said mammal a hyperglycemic amount of an arylamino benzoic acid or pharmaceutcially-acceptable salt thereof, wherein aryl represents phenyl, substituted phenyl, thienyl or substituted thienyl.

Abstract: This invention relates to compositions of 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid the corresponding pharmaceutically-acceptable salts and the esters thereof. The invention also relates to methods for reducing plasma lipid levels in mammals using the compounds and compositions.

Abstract: The present invention relates to novel monocyclic and polycyclic p-cycloalkylaminobenzoic acids, the corresponding pharmaceutically-acceptable salts and the esters thereof. This invention also relates to methods for reducing plasma lipid levels, especially cholesterol and triglyceride levels, using the compounds of the present invention.

Abstract: This invention relates to novel compounds and compositions of amino substituted arylthio-alkanoic acid, the corresponding pharmaceutically-acceptable salts and the esters thereof. The invention also relates to methods for reducing plasma lipid levels in animals using the compounds of the present invention.

Abstract: This invention relates to novel compounds and compositions of amino substituted arylthio-alkanoic acid, the corresponding pharmaceutically-acceptable salts and the esters thereof. The invention also relates to methods for reducing plasma lipid levels in animals using the compounds of the present invention.

Abstract: Novel 2-((3,5-di-tert-butyl-4-hydroxyphenyl)thio)carboxamides and compositions containing the compounds are disclosed. A method for reducing blood serum lipids using the compounds and compositions of the invention is also disclosed.

Abstract: Novel 2-((3,5-di-tert-butyl-4-hydroxyphenyl)-thio)carboxamides and compositions containing the compounds are disclosed. A method for reducing blood serum lipids using the compounds and compositions of the invention is also disclosed.